July 2017 FDA Recall Drug by Chiavna Saffron Llc
D-1145-2017 - Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

This Class I drug recall was voluntarily initiated by Chiavna Saffron Llc on July 21, 2017 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda;fda analysis found product to be tainted with sildendafil and tadalafil. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1145-2017

Reason for Recall
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
Initiated
07-21-2017
Reported
09-20-2017
Quantity
211 bottles; 339 boxes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

Batch or Lot Expiration Information

Lot# a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020